CINECA IRIS Institutional Research Information System

FALLAHI, POUPAK
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.936
AS - Asia 10.674
EU - Europa 8.380
SA - Sud America 2.014
Continente sconosciuto - Info sul continente non disponibili 1.194
AF - Africa 367
OC - Oceania 23
Totale 47.588
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.277
IT - Italia 3.312
SG - Singapore 3.253
CN - Cina 2.864
HK - Hong Kong 1.907
BR - Brasile 1.680
SE - Svezia 1.233
VN - Vietnam 1.080
BG - Bulgaria 710
DE - Germania 619
FI - Finlandia 528
CA - Canada 480
FR - Francia 431
RU - Federazione Russa 410
GB - Regno Unito 394
TR - Turchia 387
IN - India 231
UA - Ucraina 184
JP - Giappone 138
IQ - Iraq 125
AR - Argentina 115
BD - Bangladesh 113
NL - Olanda 112
KR - Corea 106
CI - Costa d'Avorio 84
MX - Messico 78
PL - Polonia 65
CH - Svizzera 61
ID - Indonesia 61
ZA - Sudafrica 61
ES - Italia 60
AT - Austria 55
PK - Pakistan 52
EC - Ecuador 48
SA - Arabia Saudita 47
CO - Colombia 43
MA - Marocco 41
SN - Senegal 41
BE - Belgio 38
UZ - Uzbekistan 37
VE - Venezuela 37
NG - Nigeria 32
PH - Filippine 31
PY - Paraguay 31
IE - Irlanda 25
KE - Kenya 24
CZ - Repubblica Ceca 22
MY - Malesia 22
JO - Giordania 21
TN - Tunisia 21
AE - Emirati Arabi Uniti 20
AU - Australia 20
NP - Nepal 20
UY - Uruguay 20
JM - Giamaica 18
LT - Lituania 18
PE - Perù 17
TH - Thailandia 17
EG - Egitto 16
IR - Iran 16
RO - Romania 16
IL - Israele 15
OM - Oman 14
DZ - Algeria 13
GR - Grecia 13
GT - Guatemala 13
KZ - Kazakistan 13
CL - Cile 12
AL - Albania 11
PT - Portogallo 11
BJ - Benin 10
DO - Repubblica Dominicana 10
LB - Libano 10
RS - Serbia 10
TT - Trinidad e Tobago 10
HN - Honduras 9
TW - Taiwan 9
PA - Panama 8
BO - Bolivia 7
CR - Costa Rica 7
GE - Georgia 7
NI - Nicaragua 7
AZ - Azerbaigian 6
BH - Bahrain 6
BY - Bielorussia 6
EU - Europa 6
HU - Ungheria 6
PS - Palestinian Territory 6
BB - Barbados 5
ET - Etiopia 5
KG - Kirghizistan 5
KW - Kuwait 5
QA - Qatar 5
AM - Armenia 4
BN - Brunei Darussalam 4
BS - Bahamas 4
DK - Danimarca 4
EE - Estonia 4
GY - Guiana 4
MN - Mongolia 4
Totale 46.333
Salva come PNG Salva come JPEG
Città #
Ashburn 2.538
Fairfield 2.489
Woodbridge 2.052
Hong Kong 1.885
Singapore 1.839
Houston 1.395
Dallas 1.393
San Jose 1.289
Chandler 1.180
Ann Arbor 1.165
Santa Clara 1.133
Seattle 1.078
Serra 989
Wilmington 864
Cambridge 863
Sofia 709
Shanghai 697
Milan 663
Beijing 612
New York 503
Council Bluffs 397
Boardman 366
Princeton 343
Pisa 318
Los Angeles 315
Ottawa 314
Lawrence 286
Helsinki 277
Medford 266
Lauterbourg 253
Ho Chi Minh City 236
Nanjing 195
Jacksonville 186
Des Moines 183
Izmir 181
Dong Ket 174
Hefei 153
Munich 151
Hanoi 149
São Paulo 141
Columbus 133
Istanbul 132
Florence 128
Buffalo 124
Redondo Beach 124
San Diego 124
Tokyo 124
London 122
Rome 121
The Dalles 114
Frankfurt am Main 108
Seoul 102
Dearborn 87
Abidjan 84
Boulder 65
Nanchang 63
Chicago 56
Rio de Janeiro 56
Ogden 55
Kunming 52
Changsha 48
Paris 47
Phoenix 47
Redwood City 47
Bremen 46
Da Nang 45
Shenyang 44
Turku 44
Warsaw 44
Falls Church 42
Dakar 41
Hebei 41
Fuzhou 40
Norwalk 40
Nuremberg 39
Baghdad 38
Belo Horizonte 37
Brooklyn 37
Brussels 37
Tashkent 36
Bern 34
Toronto 34
Orem 33
San Francisco 33
Amsterdam 32
Johannesburg 32
Montreal 32
Pune 32
Washington 32
Jüchen 31
Vienna 31
Tianjin 29
Dhaka 28
Jiaxing 28
Brasília 27
Haiphong 27
Jakarta 26
Lagos 26
Chennai 25
Curitiba 25
Totale 33.631
Salva come PNG Salva come JPEG
Nome #
A new class of tyrosine kinase inhibitors, “pyrazolo[3,4-d]pyrimidinic”compounds, has antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer 375
Autoimmune thyroid disorders 319
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 255
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 248
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 248
Hepatitis C Virus Infection: Evidence for an Association With Type 2 Diabetes: Response to Skowronski et al. 247
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 238
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 231
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2. 229
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 227
Molecular testing in the diagnosis of differentiated thyroid carcinomas 227
Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. 227
Sorafenib in the treatment of thyroid cancer 226
Aggressive thyroid cancer: targeted therapy with sorafenib 224
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 221
Sunitinib in the treatment of thyroid cancer 221
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors 217
Comparison between ethanol sclerotherapy and emptying with injection of saline in treatment of thyroid cysts. 216
3,5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats 216
Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature 216
Evaluation of the Anti-Spike (RDB) IgG Titer among Workers Employed at the University of Pisa Vaccinated with Different Types of SARS-CoV-2 Vaccines 215
Sorafenib and Thyroid Cancer 214
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 210
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 209
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 209
B-cells and mixed cryoglobulinemia. 208
Analysis of survival at cardiac arrest in events occurred in work environments in the territory served by an operations center of the 118 of Tuscany 204
Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy. 202
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients 201
Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study 201
TSH Normalization in Bariatric Surgery Patients After the Switch from l-Thyroxine in Tablet to an Oral Liquid Formulation 200
Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. 199
Putative biomarkers for malignant pleural mesothelioma suggested by proteomic analysis of cell line secretome 198
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 197
Selective use of vandetanib in the treatment of thyroid cancer 196
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy 195
Changes in autonomic regulation and ventricular repolarization induced by subclinical hyperthyroidism 194
Biomarkers in the prevention and follow-up of workers exposed to asbestos 194
Cabozantinib in Thyroid Cancer 194
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors 194
HCV-related autoimmune and neoplastic disorders: the HCV syndrome 193
Cancer stem cells: perspectives of new therapeutical approaches for breast cancer 193
Increased CXCL9 Serum Levels in Hepatitis C-Related Mixed Cryoglobulinemia, with Autoimmune Thyroiditis, Associated with High Levels of CXCL10 192
New insight in endocrine-related adverse events associated to immune checkpoint blockade 192
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 191
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied 190
Novel therapies for thyroid autoimmune diseases: An update 190
Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident 189
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 189
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture 188
Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone 188
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 188
Body composition and cardiac dimensions in elite rhythmic gymnasts 188
L’esperienza della Medicina del Lavoro della Azienda Ospedaliero-Universitaria Pisana nella sorveglianza sanitaria degli ex-esposti ad amianto, alla luce delle linee di indirizzo della regione Toscana 186
Thyroid disorders induced by checkpoint inhibitors 186
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses 186
The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition 185
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ 184
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 184
DICER1 Syndrome: A Multicenter Surgical Experience and Systematic Review 183
CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes 183
Myo-inositol in autoimmune thyroiditis, and hypothyroidism 182
Cytokines and HCV-Related Disorders. 179
Cytokines and HCV-related autoimmune disorders 179
Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study 178
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 177
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients 177
Novel treatments for anaplastic thyroid carcinoma 177
Genotoxicity Evaluation of the Soybean Isoflavone Genistein in Human Papillary Thyroid Cancer Cells. Study of Its Potential Use in Thyroid Cancer Therapy 177
RET TKI: Potential Role in Thyroid Cancers 175
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer. 175
Big and Free Fractions of Gamma-Glutamyltransferase: New Diagnostic Biomarkers for Malignant Mesothelioma? 175
An iron regulatory gene signature in breast cancer: More than a prognostic genetic profile? 174
Analysis of chromosome damage in circulating lymphocytes of radiological workers affected by thyroid nodules 172
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C 171
New targeted molecular therapies for dedifferentiated thyroid cancer. 169
Thyroid cancer in HCV-related mixed cryoglobulinemia patients. 167
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 167
3,5-diiodo-l-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects. 166
The Endocrinology of Liver Disease. 166
Stem cells: their role in breast cancer development and resistance to treatment. 166
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests 166
The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine 166
New targeted therapies for anaplastic thyroid cancer. 165
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 164
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 164
β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-α agonists in Graves' ophthalmopathy 164
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 163
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 163
Thyroid involvement in hepatitis C - Associated mixed cryoglobulinemia 163
Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy 163
The association of Sjögren syndrome and autoimmune thyroid disorders 162
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 162
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 162
Chemokines in thyroid autoimmunity 160
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update 160
Immune and inflammatory cells in thyroid cancer microenvironment 160
Thyroid uptake of 67Ga-citrate is associated with thyroid autoimmunity and hypothyroidism in patients with sarcoidosis. 159
Current and future immunotherapies for thyroid cancer 159
Serum mesothelin and other biomarkers: What have we learned in the last decade? 159
Totale 19.363
Salva come PNG Salva come JPEG
Categoria #
all - tutte 139.986
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.986
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.308 0 154 119 214 554 460 97 223 171 145 228 943
2022/20233.428 502 409 225 306 373 504 58 249 498 15 242 47
2023/20242.900 290 325 359 228 426 521 144 107 47 54 100 299
2024/20259.576 203 372 132 586 885 1.130 776 543 880 1.213 1.005 1.851
2025/202612.008 860 1.377 1.583 988 1.012 1.097 1.767 559 687 1.201 382 495
2026/2027488 420 68 0 0 0 0 0 0 0 0 0 0
Totale 47.588